Dauwe Pharma Consultancy

Kontich ·KBO/BCE: BE 0786.571.119

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	70.1%	60.6%	better than 63% of 12430 sector peers
Net result	€499	€31k	better than 16% of 12432 sector peers
Equity	€169k	€63k	better than 81% of 12438 sector peers
Gross operating margin	€-4k	€52k	better than 7% of 12418 sector peers
Total assets	€241k	€124k	better than 74% of 12431 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€241k
Current assets	29/58	€241k
Amounts receivable within one year	40/41	€77k
Cash & bank	54/58	€160k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€241k
Equity	10/15	€169k
Contributions / capital	10/11	€2k
Reserves	13	€160k
Accumulated profits (losses)	14	€7k
Amounts payable	17/49	€72k
Amounts payable within one year	42/48	€72k
Trade debts payable within one year	44	€1k
Income statement
Gross operating margin	9900	€-4k
Operating result	9901	€-4k
Financial income	75	€5k
Financial charges	65	€69
Result before taxes	9903	€623
Income taxes	67/77	€125
Net result for the period	9904	€499
Result to be appropriated	9905	€499

Summary